RE:RE:RE:RE:RE:Softening up for a stink bid? I totally agree there Eoganacht. We don't know how or why this bladder volume error occurred, but it definitely set the protocol straight once and for all. It will ensure that no Urologist ever makes that mistake again as we now know one cannot compromise on bladder volume regardless of green light intensity.IMO
Eoganacht wrote: It is not a question of loyalty. It's a question of integrity. I believe Dr. Kulkarni will go with the solution which is most beneficial for cancer patients. If he put patient's lives at risk to make a few extra dollars he would not be a doctor. Just another dirty moneygrubber.
CAinPlap wrote: Hachet or Hachey job? ;)
To be fair, doubt trial "misstake" was her fault. It is Dr. K's loyalty we need to question given his involvement with much larger, deeper pocketed companies.
floatinketucky wrote: Seems to me the same template for Phase 1 would have been used with simple write in for the allowance of the 2nd treatment.
It's really a slap in the face for the company and shareholders.
What if Covid had not caused the delay??
Jeez....
The company has accepted the blame and given the hospitial immunity from neglagance. And really the company had no choice if the wanted to the study to progress.
What a hachet job to come out of the gate with.